Design Therapeutics, Inc(NASDAQ:DSGN) 
Design Therapeutics, Inc. develops therapies for the treatment of degenerative disorders caused by nucleotide repeat expansions. The company engages in the development of a program for the treatment of Friedreich's ataxia and degenerative diseases such as Fragile X syndrome and myotonic dystrophy. T...
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating expenses: | |||||||||||||||||||
research and development | 14,589,000 | 15,738,000 | 15,377,000 | 12,157,000 | 11,876,000 | 10,516,000 | 9,801,000 | 11,012,000 | 13,257,000 | 17,064,000 | 15,730,000 | 14,255,000 | 14,304,000 | 11,295,000 | 8,759,000 | 7,337,000 | 8,539,000 | 5,027,000 | 3,875,000 |
general and administrative | 4,722,000 | 5,831,000 | 5,041,000 | 4,537,000 | 4,370,000 | 4,527,000 | 4,599,000 | 4,109,000 | 5,565,000 | 5,532,000 | 5,921,000 | 5,137,000 | 4,888,000 | 4,344,000 | 4,611,000 | 3,790,000 | 2,798,000 | 2,660,000 | 1,805,000 |
total operating expenses | 19,311,000 | 21,569,000 | 20,418,000 | 16,694,000 | 16,246,000 | 15,043,000 | 14,400,000 | 15,121,000 | 18,822,000 | 22,596,000 | 21,651,000 | 19,392,000 | 19,192,000 | 15,639,000 | 13,370,000 | 11,127,000 | 11,337,000 | 7,687,000 | 5,680,000 |
income from operations | -19,311,000 | -21,569,000 | -20,418,000 | -16,694,000 | -16,246,000 | -15,043,000 | -14,400,000 | -15,121,000 | -18,822,000 | -22,596,000 | -21,651,000 | -19,392,000 | -19,192,000 | -15,639,000 | -13,370,000 | -11,127,000 | -11,337,000 | -7,687,000 | -5,680,000 |
yoy | 18.87% | 43.38% | 41.79% | 10.40% | -13.69% | -33.43% | -33.49% | -22.02% | -1.93% | 44.48% | 61.94% | 74.28% | 69.29% | 103.45% | 135.39% | ||||
qoq | -10.47% | 5.64% | 22.31% | 2.76% | 8.00% | 4.47% | -4.77% | -19.66% | -16.70% | 4.36% | 11.65% | 1.04% | 22.72% | 16.97% | 20.16% | -1.85% | 47.48% | 35.33% | |
interest income | 2,314,000 | 2,486,000 | 2,703,000 | ||||||||||||||||
net income | -16,997,000 | -19,083,000 | -17,715,000 | -13,651,000 | -13,039,000 | -11,793,000 | -11,105,000 | -11,842,000 | -15,789,000 | -19,937,000 | -19,294,000 | -17,340,000 | -17,704,000 | -14,999,000 | -13,265,000 | -11,065,000 | -11,318,000 | -7,636,000 | -5,514,000 |
yoy | 30.36% | 61.82% | 59.52% | 15.28% | -17.42% | -40.85% | -42.44% | -31.71% | -10.82% | 32.92% | 45.45% | 56.71% | 56.42% | 96.42% | 140.57% | ||||
qoq | -10.93% | 7.72% | 29.77% | 4.69% | 10.57% | 6.20% | -6.22% | -25.00% | -20.81% | 3.33% | 11.27% | -2.06% | 18.03% | 13.07% | 19.88% | -2.24% | 48.22% | 38.48% | |
net income per share | -0.3 | -0.34 | -0.31 | -0.24 | -0.23 | -0.21 | -0.2 | -0.21 | -0.28 | -0.36 | -0.35 | -0.31 | -0.32 | -0.27 | -0.24 | -0.2 | -0.21 | -0.14 | -0.31 |
weighted-average shares of common stock outstanding, basic and diluted | 56,950,999 | 56,859,388 | 56,757,827 | 56,587,142 | 56,620,731 | 56,555,960 | 56,488,527 | 55,984,670 | 55,988,691 | 55,948,990 | 55,908,033 | 55,707,517 | 55,782,329 | 55,670,780 | 55,507,338 | 45,936,235 | 55,155,030 | 55,081,397 | 17,630,178 |
other income | 2,438,000 | 3,207,000 | 3,250,000 | 3,295,000 | 3,279,000 | 3,033,000 | 2,659,000 | 2,357,000 | 2,052,000 | 1,488,000 | 640,000 | 105,000 | 62,000 | 19,000 | 51,000 | 166,000 | |||
revenue: | |||||||||||||||||||
grant revenue |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||
current assets: | |||||||||||||||||||||
cash and cash equivalents | 12,770,000 | 16,856,000 | 15,088,000 | 19,703,000 | 13,667,000 | 22,563,000 | 30,328,000 | 45,699,000 | 29,397,000 | 21,200,000 | 27,942,000 | 27,197,000 | 28,809,000 | 26,500,000 | 42,517,000 | 119,654,000 | 287,312,000 | 298,569,000 | 357,662,000 | 370,838,000 | 400,693,000 |
investment securities | 210,053,000 | 202,989,000 | 190,882,000 | 196,573,000 | 216,007,000 | 222,914,000 | 223,746,000 | 215,317,000 | 241,289,000 | 260,598,000 | 262,998,000 | 275,891,000 | 286,583,000 | 303,887,000 | 301,716,000 | 239,723,000 | 83,908,000 | 85,495,000 | 36,056,000 | 31,998,000 | 10,646,000 |
prepaid expenses and other current assets | 4,226,000 | 3,939,000 | 3,059,000 | 3,518,000 | 3,970,000 | 2,563,000 | 3,168,000 | 3,826,000 | 3,200,000 | 2,786,000 | 3,603,000 | 2,957,000 | 3,547,000 | 4,732,000 | 1,371,000 | ||||||
total current assets | 227,049,000 | 223,784,000 | 209,029,000 | 219,794,000 | 233,644,000 | 248,040,000 | 257,242,000 | 264,842,000 | 273,886,000 | 284,584,000 | 294,543,000 | 306,045,000 | 318,939,000 | 335,119,000 | 348,488,000 | 361,722,000 | 373,871,000 | 385,435,000 | 395,290,000 | 404,875,000 | 411,754,000 |
property and equipment | 824,000 | 981,000 | 1,104,000 | 1,258,000 | 1,377,000 | 1,410,000 | 1,559,000 | 1,728,000 | 1,718,000 | 1,691,000 | 1,778,000 | 1,861,000 | 1,905,000 | 1,947,000 | 1,842,000 | 1,804,000 | 1,448,000 | 1,508,000 | 1,320,000 | 271,000 | 100,000 |
right-of-use asset | 2,569,000 | 3,743,000 | |||||||||||||||||||
total assets | 230,442,000 | 226,203,000 | 211,770,000 | 222,886,000 | 237,475,000 | 252,093,000 | 261,629,000 | 269,582,000 | 278,793,000 | 289,643,000 | 299,869,000 | 311,630,000 | 324,743,000 | 341,137,000 | 354,569,000 | 367,932,000 | 378,801,000 | 390,557,000 | 400,353,000 | 405,146,000 | 411,854,000 |
liabilities and stockholders’ equity | |||||||||||||||||||||
current liabilities: | |||||||||||||||||||||
accounts payable | 2,276,000 | 2,312,000 | 1,913,000 | 1,013,000 | 3,180,000 | 2,186,000 | 1,470,000 | 1,297,000 | 1,372,000 | 1,940,000 | 2,207,000 | 1,922,000 | 2,744,000 | 3,025,000 | 2,622,000 | 2,071,000 | 1,901,000 | 1,620,000 | 2,216,000 | 1,585,000 | 2,033,000 |
accrued expenses and other current liabilities | 7,914,000 | 10,743,000 | 9,260,000 | 7,734,000 | 5,056,000 | 6,276,000 | 5,962,000 | 5,097,000 | 5,722,000 | 7,682,000 | 10,183,000 | 10,211,000 | 6,303,000 | 7,751,000 | 7,790,000 | 5,317,000 | 3,579,000 | 3,663,000 | 3,289,000 | ||
total current liabilities | 10,190,000 | 13,055,000 | 11,173,000 | 8,747,000 | 8,236,000 | 8,462,000 | 7,432,000 | 6,394,000 | 7,094,000 | 9,622,000 | 12,390,000 | 12,133,000 | 9,047,000 | 10,776,000 | 10,412,000 | 7,388,000 | 5,480,000 | 5,283,000 | 5,505,000 | 3,405,000 | 3,706,000 |
operating lease liability | 2,198,000 | 3,273,000 | |||||||||||||||||||
total liabilities | 12,388,000 | 13,700,000 | 12,050,000 | 9,849,000 | 9,556,000 | 9,996,000 | 9,176,000 | 8,340,000 | 9,236,000 | 11,956,000 | 14,912,000 | 14,835,000 | 11,925,000 | 13,827,000 | 13,631,000 | 10,769,000 | 8,492,000 | 8,427,000 | 8,789,000 | 3,545,000 | 3,848,000 |
commitments and contingencies | |||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||
common stock, 0.0001 par value... | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | ||||||
additional paid-in capital | 532,958,000 | 509,100,000 | 480,365,000 | 476,738,000 | 472,392,000 | 468,830,000 | 465,096,000 | 461,977,000 | 458,449,000 | 455,245,000 | 452,018,000 | 448,784,000 | 444,852,000 | 441,424,000 | 438,217,000 | 435,192,000 | 432,346,000 | 429,824,000 | 427,953,000 | 426,680,000 | 425,435,000 |
accumulated deficit | -314,642,000 | -297,006,000 | -281,009,000 | -264,012,000 | -244,929,000 | -227,214,000 | -213,563,000 | -200,524,000 | -188,731,000 | -177,626,000 | -165,784,000 | -149,995,000 | -130,058,000 | -110,764,000 | -93,424,000 | -75,720,000 | -60,721,000 | -47,456,000 | -36,391,000 | -25,073,000 | -17,437,000 |
accumulated other comprehensive income | -268,000 | 403,000 | 358,000 | 305,000 | 450,000 | 475,000 | 914,000 | -217,000 | -167,000 | -244,000 | -4,000 | -12,000 | 2,000 | ||||||||
total stockholders’ equity | 218,054,000 | 199,720,000 | 213,037,000 | 227,919,000 | 252,453,000 | 261,242,000 | 269,557,000 | 284,957,000 | 296,795,000 | 312,818,000 | 340,938,000 | 357,163,000 | 370,309,000 | 391,564,000 | 401,601,000 | 408,006,000 | |||||
total liabilities and stockholders’ equity | 230,442,000 | 211,770,000 | 222,886,000 | 237,475,000 | 261,629,000 | 269,582,000 | 278,793,000 | 299,869,000 | 311,630,000 | 324,743,000 | 354,569,000 | 367,932,000 | 378,801,000 | ||||||||
right-of-use asset, related party | 1,438,000 | 1,637,000 | 1,834,000 | 2,027,000 | 2,216,000 | 2,401,000 | 2,583,000 | 2,762,000 | 2,938,000 | 3,111,000 | 3,280,000 | 3,447,000 | 3,612,000 | 3,773,000 | 3,932,000 | 3,482,000 | 3,614,000 | ||||
other assets | 427,000 | 427,000 | 427,000 | 429,000 | 427,000 | 430,000 | 437,000 | 444,000 | 452,000 | 459,000 | 466,000 | 474,000 | |||||||||
liabilities and stockholders' equity | |||||||||||||||||||||
operating lease liability, net, related party | 645,000 | 877,000 | 1,102,000 | 1,320,000 | 1,534,000 | 1,744,000 | 1,946,000 | 2,142,000 | 2,334,000 | 2,522,000 | 2,702,000 | 2,878,000 | 3,051,000 | 3,219,000 | 3,381,000 | 3,012,000 | 3,144,000 | ||||
stockholders' equity: | |||||||||||||||||||||
common stock: 0.0001 par value... | 6,000 | 6,000 | 6,000 | 6,000 | 6,000 | ||||||||||||||||
total stockholders' equity | 212,503,000 | 242,097,000 | 277,687,000 | 327,310,000 | 382,130,000 | ||||||||||||||||
total liabilities and stockholders' equity | 226,203,000 | 252,093,000 | 289,643,000 | 341,137,000 | |||||||||||||||||
accumulated other comprehensive loss | 62,000 | -1,283,000 | -2,000,000 | -1,982,000 | -3,356,000 | -3,861,000 | -2,315,000 | -1,322,000 | |||||||||||||
prepaid expense and other current assets | 4,255,000 | 2,345,000 | 2,651,000 | 1,572,000 | 2,039,000 | 415,000 | |||||||||||||||
deferred offering costs | |||||||||||||||||||||
liabilities, convertible preferred stock and stockholders' equity | |||||||||||||||||||||
other long-term liabilities | 11,000 | 140,000 | 142,000 | ||||||||||||||||||
convertible preferred stock; 0.0001 par value... | |||||||||||||||||||||
stockholders' equity | |||||||||||||||||||||
total liabilities, convertible preferred stock and stockholders' equity | 390,557,000 | ||||||||||||||||||||
liabilities, convertible preferred stock and stockholders’ equity | |||||||||||||||||||||
convertible preferred stock, 0.0001 par value... | |||||||||||||||||||||
stockholders’ equity | |||||||||||||||||||||
total liabilities, convertible preferred stock and stockholders’ equity | 400,353,000 | 405,146,000 | 411,854,000 | ||||||||||||||||||
accrued expenses | 1,820,000 | 1,673,000 | |||||||||||||||||||
common stock, par value 0.0001... | 6,000 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||
net loss | -17,636,000 | -15,997,000 | -16,997,000 | -19,083,000 | -17,715,000 | -13,651,000 | -13,039,000 | -11,793,000 | -11,105,000 | -11,842,000 | -15,789,000 | -19,937,000 | -19,294,000 | -17,340,000 | -17,704,000 | -14,999,000 | -13,265,000 | -11,065,000 | -11,318,000 | -7,636,000 | -5,514,000 |
reconciliation of net loss to net cash from operating activities: | |||||||||||||||||||||
depreciation | 157,000 | 156,000 | 155,000 | 152,000 | 159,000 | 149,000 | 153,000 | 151,000 | 143,000 | 138,000 | 137,000 | 133,000 | 129,000 | 124,000 | 108,000 | 92,000 | 82,000 | 82,000 | 31,000 | 12,000 | 4,000 |
stock-based compensation | 3,924,000 | 3,435,000 | 3,590,000 | 3,985,000 | 3,539,000 | 3,471,000 | 3,118,000 | 3,299,000 | 3,184,000 | 2,724,000 | 3,219,000 | 3,719,000 | 3,426,000 | 3,076,000 | 2,872,000 | 2,617,000 | 2,360,000 | 1,556,000 | 1,243,000 | 1,243,000 | 647,000 |
amortization of premiums on investment securities | -147,000 | -512,000 | -767,000 | -914,000 | -1,060,000 | -1,438,000 | -1,456,000 | -1,573,000 | -1,731,000 | -1,836,000 | -1,709,000 | -1,397,000 | -1,142,000 | -899,000 | -458,000 | -58,000 | 19,000 | 26,000 | 25,000 | 22,000 | -150,000 |
non-cash lease expense | 69,000 | -8,000 | -7,000 | -2,000 | -4,000 | -3,000 | 1,000 | 4,000 | 4,000 | 5,000 | 8,000 | 10,000 | 10,000 | 11,000 | 14,000 | 21,000 | 14,000 | ||||
change in operating assets and liabilities: | |||||||||||||||||||||
prepaid expense and other assets | -287,000 | -880,000 | 459,000 | 452,000 | -1,407,000 | 605,000 | 660,000 | -628,000 | -411,000 | 823,000 | -639,000 | 598,000 | 1,192,000 | -471,000 | -1,902,000 | 217,000 | -1,237,000 | 141,000 | 466,000 | ||
accounts payable and other liabilities | -2,511,000 | 1,840,000 | 2,405,000 | 542,000 | -301,000 | 1,007,000 | 1,017,000 | -720,000 | -2,523,000 | -2,810,000 | 239,000 | 3,070,000 | -1,745,000 | 431,000 | 3,156,000 | 1,598,000 | 215,000 | -26,000 | |||
net cash from operating activities | -16,431,000 | -11,966,000 | -11,162,000 | -14,441,000 | -16,789,000 | -9,860,000 | -9,546,000 | -11,260,000 | -12,439,000 | -12,798,000 | -14,534,000 | -13,804,000 | -17,424,000 | -15,091,000 | -13,899,000 | -10,500,000 | -11,827,000 | -9,227,000 | -8,164,000 | -8,289,000 | -3,697,000 |
capital expenditures | -34,000 | 0 | -87,000 | -18,000 | 0 | 16,000 | -161,000 | -195,000 | -27,000 | -53,000 | -89,000 | -288,000 | -473,000 | -41,000 | -57,000 | -354,000 | -968,000 | -183,000 | -33,000 | ||
free cash flows | -12,000,000 | -11,162,000 | -14,528,000 | -16,807,000 | -9,860,000 | -9,530,000 | -11,421,000 | -12,634,000 | -12,825,000 | -14,587,000 | -13,893,000 | -15,379,000 | -14,372,000 | -10,541,000 | -11,884,000 | -9,581,000 | -9,132,000 | -8,472,000 | -3,730,000 | ||
cash flows from investing activities | |||||||||||||||||||||
purchases of investment securities | -52,589,000 | -87,624,000 | -78,075,000 | -39,532,000 | -86,548,000 | -64,373,000 | -66,512,000 | -53,631,000 | -45,659,000 | -74,153,000 | -54,566,000 | -62,369,000 | -33,615,000 | -61,008,000 | -94,014,000 | -49,905,000 | -4,319,000 | -26,926,000 | -5,111,000 | ||
proceeds from maturities of investment securities | 45,000,000 | 76,075,000 | 84,585,000 | 59,735,000 | 94,490,000 | 66,205,000 | 60,670,000 | 81,125,000 | 66,470,000 | 79,735,000 | 69,885,000 | 74,440,000 | 53,435,000 | 60,240,000 | 30,935,000 | 1,225,000 | 490,000 | 200,000 | 245,000 | 5,538,000 | 28,172,000 |
purchases of property and equipment | -34,000 | 0 | -87,000 | -72,000 | 0 | 16,000 | -161,000 | -195,000 | -27,000 | -53,000 | -89,000 | -87,000 | -288,000 | -310,000 | -244,000 | -76,000 | -354,000 | -968,000 | -183,000 | -33,000 | |
net cash from investing activities | -7,589,000 | -11,583,000 | 6,510,000 | 20,116,000 | 7,870,000 | 1,832,000 | -5,826,000 | 27,333,000 | 20,616,000 | 15,266,000 | 11,982,000 | 19,733,000 | -1,056,000 | -63,389,000 | -156,956,000 | 414,000 | -50,059,000 | -5,042,000 | -21,571,000 | 23,028,000 | |
cash flows from financing activities | |||||||||||||||||||||
proceeds from the issuance of common stock in at-the-market offering, net of issuance costs | 19,907,000 | ||||||||||||||||||||
proceeds from the exercise of stock options | 27,000 | 182,000 | 37,000 | 0 | 23,000 | 9,000 | 1,000 | 6,000 | 20,000 | 402,000 | 13,000 | 16,000 | 151,000 | 0 | 156,000 | ||||||
net cash from financing activities | 19,934,000 | 25,317,000 | 37,000 | 361,000 | 23,000 | 263,000 | 1,000 | 229,000 | 20,000 | 501,000 | 13,000 | 130,000 | 151,000 | -202,000 | 156,000 | 193,000 | 30,000 | 5,000 | 378,983,000 | ||
net decrease in cash and cash equivalents | -4,086,000 | ||||||||||||||||||||
cash and cash equivalents at beginning of period | 16,856,000 | 0 | 0 | 0 | 22,563,000 | 0 | 0 | 0 | 21,200,000 | 0 | 0 | 0 | 26,500,000 | 0 | 0 | 0 | 298,569,000 | 0 | 0 | 0 | 2,379,000 |
cash and cash equivalents at end of period | 12,770,000 | 1,768,000 | -4,615,000 | 6,036,000 | 13,667,000 | -7,765,000 | -15,371,000 | 16,302,000 | 29,397,000 | -6,742,000 | 745,000 | -1,612,000 | 28,809,000 | -16,017,000 | -77,137,000 | -167,658,000 | 287,312,000 | -59,093,000 | -13,176,000 | -29,855,000 | 400,693,000 |
supplemental disclosures | |||||||||||||||||||||
increase in right-of-use-asset and operating lease liability related to lease amendment | 1,295,000 | ||||||||||||||||||||
purchases of property and equipment included in accounts payable and accrued expenses | 54,000 | -163,000 | 203,000 | 19,000 | |||||||||||||||||
deferred financing costs | 0 | 0 | |||||||||||||||||||
issuance of common stock through employee stock purchase plan | 288,000 | 0 | 254,000 | 0 | 99,000 | 0 | 114,000 | 0 | |||||||||||||
issuance costs included in accrued expenses | |||||||||||||||||||||
net increase in cash and cash equivalents | -4,615,000 | 6,036,000 | -8,896,000 | -15,371,000 | 16,302,000 | 8,197,000 | 745,000 | -1,612,000 | 2,309,000 | -16,017,000 | -77,137,000 | -167,658,000 | -11,257,000 | -59,093,000 | -13,176,000 | -29,855,000 | 398,314,000 | ||||
purchases of property and equipment included in accrued expenses | |||||||||||||||||||||
other | 0 | 0 | |||||||||||||||||||
accounts payable and other liabilities—related party | -23,000 | 15,000 | 8,000 | -15,000 | -15,000 | ||||||||||||||||
proceeds from sale of asset | 0 | 0 | |||||||||||||||||||
net cash from (used) in investing activities | |||||||||||||||||||||
payment of deferred issuance costs | 0 | 0 | |||||||||||||||||||
initial recognition of operating lease right-of-use asset and operating lease liability | 0 | ||||||||||||||||||||
initial recognition of right-of-use asset and operating lease liability | 0 | ||||||||||||||||||||
deferred financing costs in accrued expenses | 0 | ||||||||||||||||||||
proceeds from initial public offering, net of issuance costs | 0 | 0 | 0 | 254,271,000 | |||||||||||||||||
proceeds from issuance of convertible preferred stock, net of issuance costs | 0 | 0 | 0 | 124,712,000 | |||||||||||||||||
prepaid expense and other assets—related party | 0 | 0 | -60,000 | ||||||||||||||||||
non-cash interest expense | |||||||||||||||||||||
non-cash interest expense—related party | |||||||||||||||||||||
net change in operating lease right-of-use assets and liabilities—related party | |||||||||||||||||||||
deferred revenue | |||||||||||||||||||||
other long-term liabilities | |||||||||||||||||||||
proceeds from the issuance of notes payable, net of issuance costs—related party | |||||||||||||||||||||
repayment of notes payable—related party | |||||||||||||||||||||
conversion of convertible notes to convertible preferred shares, including bifurcated conversion liability | |||||||||||||||||||||
conversion of convertible notes to convertible preferred shares, including bifurcated conversion liability - related party | |||||||||||||||||||||
interest paid | |||||||||||||||||||||
proceeds from the exercise of stock options and vesting of restricted stock | 30,000 | ||||||||||||||||||||
accounts payable and accrued liabilities | -301,000 | 1,376,000 | |||||||||||||||||||
accounts payable and accrued liabilities—related party |